Background and Need - Prior to publication in the NIOSH Manual of Analytical Methods (NMAM), all submitted methods are required to undergo a User Check, or a secondary laboratory validation. This acquisition is being pursued for two proposed methods that were developed here at NIOSH in the Biomonitoring and Health Assessment Branch. These two methods are, NIOSH 8326 - S-Benzylmercapturic acid and S-phenylmercapturic acid in urine and NIOSH 8327 - Cyclophosphamide, 4-ketocyclophosphamide and ifosfamide in urine.

Project Objective - The purpose of the acquisition is to fulfill all the requirements of User Checks as set forth by the NMAM Team. The results of the acquisition will be an independent review and validation of each of the proposed NIOSH methods which will allow their publication in the NMAM and increase their dissemination in the scientific community.

Responsible sources that believe they possess the expertise and capabilities identified above are encouraged to submit to the Contracting Officer within 15 days from the posting date of this notice, their written item description/item characteristics and pricing information in the format they choose, not to exceed 10 pages. Please forward the item description and pricing information to Denise Rains, Reference #2012-Q-14871, CDC/NIOSH, 315 East Montgomery Avenue, Spokane, WA, 99207 or email [email protected] or Fax (509)354-8099. All vendors must be registered in the Central Contractor Registry (CCR) prior to an award of a Federal contract. The website is www.ccr.gov.

The Government will review any/all item descriptions and pricing information submitted.  This is the only annuncement that will be posted.